The Economic Burden of Atherosclerotic Cardiovascular Disease in Italy Francesco S. MenniniMatteo ScortichiniPaolo Sciattella Original Research Article Open access 09 September 2024
The Cost Effectiveness of Adjunctive Treatments for Proton Pump Inhibitor-Refractory Gastroesophageal Reflux Disease Ulysses S. RosasChristopher V. AlmarioBrennan M. R. Spiegel Original Research Article Open access 07 September 2024
The Effect of Placebo on Pruritus in Patients with Chronic Urticaria: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials Peiwen XueHaiyan QinXianjun Xiao Systematic Review 06 September 2024
Cost-Effectiveness Analysis of Newborn Screening for Spinal Muscular Atrophy in Italy Gianni GhettiFrancesco Saverio MenniniMarika Pane Original Research Article Open access 22 August 2024
Efficacy and Safety of Topical Roflumilast for the Treatment of Psoriasis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Rafaela de Moraes-SouzaRegina Chahine ChaterPedro Herranz-Pinto Systematic Review Open access 22 August 2024
Correction to: AVT04: An Ustekinumab Biosimilar Hannah A. Blair Correction Open access 21 August 2024
Budget Impact of Disease-Modifying Treatments and a CRISPR Gene-Edited Therapy for Sickle Cell Disease Khadidja AbdallahIsabelle HuysSteven Simoens Original Research Article 12 August 2024 Pages: 611 - 627
Health and Economic Outcomes of Pembrolizumab in the Treatment of Metastatic Non-small Cell Lung Cancer (mNSCLC) and Melanoma in Italy Martina PaolettiChiara BiniFrancesco Saverio Mennini Original Research Article Open access 08 August 2024 Pages: 601 - 609
Expert Consensus on the Management of Adverse Events of Lorlatinib in the Treatment of ALK+ Advanced Non-small Cell Lung Cancer Edurne ArriolaJavier de CastroEnriqueta Felip Current Opinion Open access 31 July 2024 Pages: 553 - 576
Pharmacokinetics and Pharmacodynamics of Nipocalimab, a Neonatal Fc Receptor Blocker, in Healthy Japanese Volunteers Nobuko MatsushimaSayori ShibataHideo Harigae Original Research Article Open access 29 July 2024 Pages: 587 - 599
The Early Access and the Potential Cost Savings by the Compassionate Use of Onco-haematological Drugs: Results from the Italian Study Compass-O Irene Dell’AnnoLeonardo DondiCarlo Piccinni Original Research Article 20 July 2024 Pages: 577 - 586
Effectiveness and Safety of Upadacitinib for Adolescents with Atopic Dermatitis in a Real-World Setting Cataldo PatrunoGiuseppe LaulettaMaddalena Napolitano Short Communication 16 July 2024 Pages: 629 - 634
AVT04: An Ustekinumab Biosimilar Hannah A. Blair Adis Biosimilar Brief Open access 04 July 2024 Pages: 549 - 552
Selective Serotonin Reuptake Inhibitors for the Treatment of Depression in Parkinson’s Disease: A Systematic Review and Meta-Analysis Renjie GaoPanpan ZhaoKai Yan Systematic Review 03 July 2024 Pages: 459 - 469
Real-World Safety and Effectiveness of Letermovir in Patients Undergoing Allogenic Hematopoietic Stem Cell Transplantation: Final Results of Post-Marketing Surveillance in Japan Masaki FukudaJunko HattoriShinichiroh Maekawa Original Research Article Open access 27 June 2024 Pages: 527 - 540
Efficacy and Safety of BP02 (Trastuzumab Biosimilar) in HER2-Positive Metastatic Breast Cancer: A Multicenter Phase III Study M. V. T. Krishna MohanArpitkumar PrajapatiDisha Dadke Original Research Article Open access 27 June 2024 Pages: 513 - 525
Sodium Phenylbutyrate and Tauroursodeoxycholic Acid: A Story of Hope Turned to Disappointment in Amyotrophic Lateral Sclerosis Treatment Arsh KetabforoushFaezeh FaghihiW. David Arnold Review Article 23 June 2024 Pages: 495 - 512
Current Findings and Potential Mechanisms of KarXT (Xanomeline–Trospium) in Schizophrenia Treatment Ali Azargoonjahromi Review Article 21 June 2024 Pages: 471 - 493
Radiomic Parameters for the Evaluation of Response to Treatment in Metastatic Colorectal Cancer Patients with Liver Metastasis: Findings from the CAVE-GOIM mCRC Phase 2 Trial Erika MartinelliDavide CiardielloAlfonso Reginelli Short Communication 17 June 2024 Pages: 541 - 548
Drug–Drug Interactions and Their Association with Adverse Health Outcomes in the Older Community-Dwelling Population: A Prospective Cohort Study John E. HughesKathleen E. BennettCaitriona Cahir Original Research Article Open access 15 June 2024 Pages: 439 - 453
Prediction Models for Intravenous Immunoglobulin Non-Responders of Kawasaki Disease Using Machine Learning Yoshifumi MiyagiSatoru Iwashima Original Research Article 13 June 2024 Pages: 425 - 437
A Randomized Control Trial of Dexketoprofen/Vitamin B (Thiamine, Pyridoxine and Cyanocobalamin) Fixed-Dose Combination in Post-Traumatic Grade I–II Cervical Sprains Pamela Delgado-GarcíaJuan Bautista Alcocer-HerreraJorge González-Canudas Original Research Article Open access 06 June 2024 Pages: 413 - 424
Overall Survival Benefit with Sacituzumab Govitecan in Metastatic Breast Cancer: A Post Hoc Interaction Analyses of a Randomized Controlled Trail Yu-Wei QiaoGuo YuGuo-Fu Li Research Letter 05 June 2024 Pages: 455 - 457
An Early Cost-Utility Model of mRNA-Based Therapies for the Treatment of Methylmalonic and Propionic Acidemia in the United Kingdom Pablo E. Bretos-AzconaMatthew WallaceAgota Szende Original Research Article 25 May 2024 Pages: 399 - 412
Systematic Review with Meta-analysis: Efficacy and Safety of Upadacitinib in Managing Moderate-to-Severe Crohn’s Disease and Ulcerative Colitis Chengu NiuJing ZhangPatrick I. Okolo 3rd Systematic Review 23 May 2024 Pages: 371 - 385
Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Oral AL01211 in Healthy Chinese Volunteers Lei DongJianxing XiangJianhong Zheng Original Research Article 02 May 2024 Pages: 387 - 398
PB006: A Natalizumab Biosimilar Matt Shirley Adis Biosimilar Brief Open access 29 April 2024 Pages: 367 - 370
Prediction Model for Severe Thrombocytopenia Induced by Gemcitabine Plus Cisplatin Combination Therapy in Patients with Urothelial Cancer Noriaki MatsumotoTomohiro MizunoShigeki Yamada Original Research Article 29 April 2024 Pages: 357 - 366
Differential Utility Losses in Herpes Zoster Cases Between Vaccinated and Unvaccinated Subjects: A Meta-analysis of Three Clinical Trials Nikolaos GiannelosBernard FrancqDesmond Curran Original Research Article Open access 25 April 2024 Pages: 293 - 301
Safety, Tolerability, and Pharmacokinetics of Oral BI 1358894 in Healthy Japanese Male Volunteers Jangsoo YoonVikas SharmaAkiko Harada Original Research Article Open access 24 April 2024 Pages: 319 - 328
Risk of Cardiovascular Events in Schizophrenic Patients Treated with Paliperidone Palmitate Once-Monthly Injection (PP1M): A Population-Based Retrospective Cohort Study in Taiwan Shih-Pei ShenLi YanChao-Hsiun Tang Original Research Article Open access 15 April 2024 Pages: 329 - 341
Pharmacokinetic Interactions Between Tegoprazan and the Combination of Clarithromycin, Amoxicillin and Bismuth in Healthy Chinese Subjects: An Open-Label, Single-Center, Multiple-Dosage, Self-Controlled, Phase I Trial Yujing DuLixiu YuYongning Lu Original Research Article 13 April 2024 Pages: 343 - 355
Impact of Viloxazine Extended-Release Capsules (Qelbree®) on Select Cytochrome P450 Enzyme Activity and Evaluation of CYP2D6 Genetic Polymorphisms on Viloxazine Pharmacokinetics Zhao WangTesfaye LiransoAzmi Nasser Original Research Article Open access 10 April 2024 Pages: 303 - 317
Real-World Effectiveness of Once-Weekly Glucagon-Like Peptide-1 Receptor Agonists (OW GLP-1RAs) in Comparison with Dipeptidyl Peptidase-4 Inhibitors (DPP-4is) for Glycemic Control and Weight Outcomes in Type 2 Diabetes Mellitus (RELATE) Xi TanVictoria DivinoAaron A. King Original Research Article Open access 20 March 2024 Pages: 271 - 284
Experience of Tofacitinib Use in Pregnancy in Patients with Ulcerative Colitis María ChaparroDaniel CeballosJavier P. Gisbert Research Letter Open access 19 March 2024 Pages: 285 - 288
Should Glucokinase be Given a Chance in Diabetes Therapeutics? A Clinical-Pharmacological Review of Dorzagliatin and Lessons Learned So Far Upinder KaurBhairav Kumar PathakSankha Shubhra Chakrabarti Review Article 09 March 2024 Pages: 223 - 250
Effectiveness of Dose Increase in Upadacitinib from 15 mg to 30 mg for Patients with Moderate-to-Severe Atopic Dermatitis: A Real-World Clinical Practice in Japan Teppei HaginoRisa HamadaNaoko Kanda Original Research Article 06 March 2024 Pages: 261 - 269
Tolvaptan Treatment and Long-Term Impact on Quality of Life in Autosomal Dominant Polycystic Kidney Disease Patients: A Pilot Study Gianni CarraroValentina Di VicoLorenzo A. Calò Research Letter 02 March 2024 Pages: 289 - 291
An Open-Label Study to Assess Monthly Risperidone Injections (180 mg) Following Switch from Daily Oral Risperidone (6 mg) in Stable Schizophrenic Patients David P. WallingSunita N. ShindeCeline M. Laffont Original Research Article Open access 22 February 2024 Pages: 251 - 260
Cost-Effectiveness Evaluation of Oral CGRP Antagonists, Atogepant and Rimegepant, for the Preventative Treatment of Episodic Migraine: Results from a US Societal Perspective Model Ryan ThaliffdeenAnthony YuKaren Rascati Original Research Article 21 February 2024 Pages: 209 - 217
Thromboembolic Events Associated with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Pharmacovigilance Analysis of the US FDA Adverse Event Reporting System (FAERS) Database Xiongwen YangBo YangChengxiao Fu Original Research Article 20 February 2024 Pages: 199 - 207
Real-World Effectiveness of Sotrovimab for the Early Treatment of COVID-19: Evidence from the US National COVID Cohort Collaborative (N3C) Christopher F. BellPriyanka Bobbilithe N3C consortium Original Research Article Open access 20 February 2024 Pages: 183 - 198
Safety and Efficacy of Biologic Medications and Janus Kinase Inhibitors in Patients with Down Syndrome: A Retrospective Cohort Study Linnea WesterkamLauren PearsonChristopher Sayed Research Letter 19 February 2024 Pages: 219 - 222
Safety of Intravenous Push Valproate Compared with Intravenous Piggyback at a Tertiary Academic Medical Center Felicia Y. WangKevin C. McLaughlinRobert E. Dannemiller Original Research Article 16 February 2024 Pages: 175 - 181
Effect of Ticagrelor versus Clopidogrel on All-Cause and Cardiovascular Mortality in Acute Coronary Syndrome Patients with Hyperuricemia Shanshan NieYuhang ZhaoGuoping Yang Original Research Article 07 February 2024 Pages: 163 - 174
Cost-Effectiveness Analysis of Camrelizumab Plus Rivoceranib Versus Sorafenib as a First-Line Therapy for Unresectable Hepatocellular Carcinoma in the Chinese Health Care System Wenwang LangLian DengMing Ouyang Original Research Article 01 February 2024 Pages: 149 - 162
Forty-Eight-Month Monitoring of Disease Activity in Patients with Long-Standing Rheumatoid Arthritis Treated with TNF-α Inhibitors: Time for Clinical Outcome Prediction and Biosimilar vs Biologic Originator Performance Matteo ColinaMicheline KhodeirGabriele Campana Original Research Article Open access 31 January 2024 Pages: 141 - 148
Correction to: Association Between Antidiabetic Drugs and Delirium: A Study Based on the Adverse Drug Event Reporting Database in Japan Yukiko IshibashiRintaro SogawaChisato Shimanoe Correction 10 January 2024 Pages: 121 - 121
Demystifying Dry Powder Inhaler Resistance with Relevance to Optimal Patient Care Toby G. D. CapstickSanjay GudimetlaOmar S. Usmani Practical Application Open access 10 January 2024 Pages: 109 - 114